| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/22/2008 | US7361638 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect |
| 04/22/2008 | US7361637 Hypotensors |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361339 Methods for reducing morality associated with acute myocardial infarction |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2302669C Piperidinylmethyloxazolidinone derivative |
| 04/22/2008 | CA2279963C Dinucleotides and their use |
| 04/17/2008 | WO2008046087A2 Spiro compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008045688A1 Chymase inhibitors |
| 04/17/2008 | WO2008045604A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | WO2008045566A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | WO2008044862A1 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| 04/17/2008 | WO2008044785A1 Material for improvement of cerebral blood flow, and use thereof |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044659A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10 |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044217A2 2-aminocarbonyl-pyridine derivatives |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043759A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043211A1 The application of ketanserin for the manufacture of a medicament for preventing cerebral apoplexy |
| 04/17/2008 | WO2008043181A1 Augmenting stem cell populations by modulating t-cell protein tyrosine phosphatase (tc-ptp) |
| 04/17/2008 | WO2008024390A3 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 04/17/2008 | WO2007144785A3 Ryanodine receptor inhibitors and methods relating thereto |
| 04/17/2008 | WO2007139992A3 ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS |
| 04/17/2008 | WO2007118832A3 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | WO2007094027A3 Methods for the diagnosis of proliferative and/or conformational diseases |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091006 Nitrate ester cyclodextrin complexes |
| 04/17/2008 | US20080090915 Method for preventing or attenuating anthracycline-induced cardiotoxicity |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090794 Potassium Channel Inhibitors |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089947 Calcium Influx Inhibitors in the Treatment of Ischemia |
| 04/17/2008 | US20080089946 Synergistic Phytoceutical Compositions |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089876 Mixture comprising an omega three fatty acid, statin, coenzyme Q10, resveratrol, at least one policosanol, pantethine, selenium, and zinc for use in treatment and prevention of diabetes, obesity, hypertension, hyperlipidaemias and hypercholesterolaemias |
| 04/17/2008 | US20080089874 Electrophysiologically immature transgenic cell which expresses connexin for use as tool in prevention and treatment of cardiovascular disorders; regenerative medicine |
| 04/17/2008 | DE102006048693A1 Inhibition der PDE2A Inhibition of PDE2A |
| 04/17/2008 | CA2675518A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | CA2666658A1 Chymase inhibitors |
| 04/17/2008 | CA2666396A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | CA2666355A1 Inhibition of pde2a |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664826A1 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | CA2664579A1 2-aminocarbonyl-pyridine derivatives |
| 04/17/2008 | CA2663805A1 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory |
| 04/17/2008 | CA2564263A1 Cardiac reperfusion methods and devices |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911758A1 Phenyl piperidine derivatives for use as renin inhibitors |
| 04/16/2008 | EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1911746A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911462A2 Compositions comprising a sterol absorption inhibitor |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910333A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 04/16/2008 | EP1910329A1 4-chromenonyl-1,4-dihydropyridines and their use |
| 04/16/2008 | EP1910287A1 Process for the preparation of crystalline perindopril |
| 04/16/2008 | EP1910272A1 Renin inhibitors |
| 04/16/2008 | EP1909912A2 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 04/16/2008 | EP1909818A2 Use of bpi protein for treatment of diseases |